| No. 2273 February 6, 2012 |
| |
| PHARMA JAPAN is a must read for every busy executive who needs to keep up with the world's second largest health care market. |
 | |
|
P. Reed Maurer |
|
|
CMIC to Set Up Profit-Generating Mechanism for Ultra-orphan Drugs: Chairman Nakamura
|
p 1 |
|
JPWA Calls on Members to Negotiate Prices by Product Category, Conclude MOU
|
p 2 |
|
16 APIs Including Aricept, Lyrica to Be Re-Priced Following Market Expansion |
p 8 |
|
PAFSC's 1st Committee Recommends Approval for Zyprexa for Depression in Bipolar Disorders |
p 12 |
|
Guidance for FY2012 NHI Price Revisions Approved by Chuikyo | p 13 |
|
Nichi-Iko, sanofi-aventis to Jointly Develop Remicade Biosimilar |
p 18 |
|
Takeda Begins Domestic PIII Trials for New Prostate Cancer Drug |
p 20 |
|
|
